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The quali-quantitative characterization of the oral microbiota is crucial for an exhaustive knowledge 
of the oral ecology and the modifications of the microbial composition that occur during periodontal 
pathologies. In this study, we designed and validated a new phylogenetic DNA-microarray (OralArray) 
to quickly and reliably characterize the most representative bacterial groups that colonize the oral 
cavity. The OralArray is based on the Ligation Detection Reaction technology associated to Universal 
Arrays (LDR-UA), and includes 22 probe sets targeted to bacteria belonging to the phyla Firmicutes, 
Proteobacteria, Actinobacteria, Bacteroidetes, Fusobacteria, and Spirochaete. The tool is characterized 
by high specificity, sensitivity and reproducibility. The OralArray was successfully tested and validated 
on different oral samples (saliva, lingual plaque, supragingival plaque, and healing cap) collected from 
10 healthy subjects. For each specimen, a microbial signature was obtained, and our results established 
the presence of an oral microbial profile specific for each subject. Moreover, the tool was applied to 
evaluate the efficacy of a disinfectant treatment on the healing caps before their usage. The OralArray 
is, thus, suitable to study the microbiota associated with various oral sites and to monitor changes 
arising from therapeutic treatments.
Understanding the role of the microbial communities associated to the human body is emerging as one of the 
most important and fascinating biomedical challenges of our times1–3. The commensal human microbiome has 
recently been estimated to equal the amount of the human body cells4. Complex microbial communities are 
normal residents of the skin, oral cavity, vaginal, and intestinal mucosa and carry a broad range of functions 
essential for the wellbeing of the host5. When the balance of these communities is altered, opportunistic or path-
ogenic species can take over, causing, in some cases, infection and inflammation. In contrast to the traditional 
view of individual pathogens being responsible for disease onset, recent phylogenetic studies seem to point to a 
new perspective in which the transition from health to disease is attributed to a shift in the global balance of the 
microbiota rather than to the specific appearance of individual pathogens3, 6.
In recent years, next-generation massive sequencing (NGS) has allowed the complete sequencing of an ever 
increasing number of commensals and opportunistic bacteria related to human niches, such as gut, skin, vagina, 
and mouth. At the same time, NGS has been, also, applied to the description of microbial communities, increas-
ing our knowledge of the microbiome inhabitants7.
Efforts to characterize microbial diversity increasingly, at present, rely on cultivation-independent, molecular 
techniques8, 9, since the vast majority of bacteria are not cultivable. Most of these molecular studies are based on 
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the small subunit (16 S) of ribosomal RNA (rRNA) gene because of its universal presence in cellular organisms, 
the presence of conserved regions, and its reliability for phylogenetic analysis10.
Using rRNA gene-based techniques, it is estimated that the human oral cavity harbors ca. 700 different bacte-
rial species11–13, that reach the number of 1011 CFU/g in dental plaque and 108–109 CFU/g in saliva14, 15. Some of 
these bacteria are closely related to the development of oral diseases, mainly dental caries and periodontitis9, 16. 
The oral microbiota also seems to be involved in several non-oral diseases, such as bacterial endocarditis, heart 
disease, obesity, pneumonia, atherosclerosis, and preterm low birth weight17–22.
Phylogenetic DNA-microarrays have been recognized in the scientific community as valuable tools for a 
high-throughput, quantitative and systematic analysis of bacterial communities in different human microbial 
ecosystems23–26, including the oral microbiota24. The objective of the present study was to develop a new phyloge-
netic DNA-microarray, named OralArray, to quickly and reliably characterize a selected core of representative 
bacterial groups that colonize different sites of the oral cavity. The peculiarity of the OralArray is the association 
of the Ligation Detection Reaction technology with Universal Arrays (LDR-UA)27–29. This technique relies on 
the ligation of two probe types (one labeled Discriminating Probe, DP; and one Common Probe, CP, forming 
together one probe set), operated by a ligase upon perfect match with the target molecule. The ligation event is 
visualized on a UA carrying Zip Codes, a set of artificial sequences, that are complementary to the cZip Codes 
fused to CPs.
The OralArray was successfully tested and validated on different oral samples, saliva, lingual plaque, suprag-
ingival plaque and healing cap (control and pretreated with chlorhexidine), demonstrating its potential to study 
the microbiota associated with various oral sites and to monitor changes arising from therapeutic treatments.
Results
Probe panel of the OralArray. Based on the literature available in the field of human oral ecosystem and 
the most relevant oral pathologies3, 5, 30–34, twenty two bacterial targets were selected (Table 1) and specific probe 
sets were designed by using ORMA probe designer tool35, as described in Materials and Methods section. A phy-
logenetic tree was built by using all positive sets (Fig. 1). The targets belong to the prokaryotic phyla Firmicutes, 
Proteobacteria, Actinobacteria, Bacteroidetes, Fusobacteria, and Spirochaetes, which account for 96% of the species 
detected in the oral microbiome5, 32. The probes were designed to cover different phylogenetic levels, from a single 
representative species, to entire genera. Within Firmicutes, the genus Streptococcus is the most representative in 
the mouth: a probe set targeting S. oralis and its related species (i.e. S. mitis, S. infantis, S. pneumoniae) and one 
set targeting the cariogenic species S. mutans were designed. The other known cariogenic species Lactobacillus 
acidophilus was addressed by a specific probe set previously designed and validated on a LDR-UA platform for 
the characterization of the vaginal microbiota (VaginArray26). The Firmicutes genera Gemella and Staphylococcus 
are, also, extremely common in the oral ecosystem, thus they were targeted by using genus-level probe sets; 
Staphylococcus probe set was mutuated from the VaginArray26. Within the Clostridia class of Firmicutes, the spe-
cies Parvimonas micra was selected as recurrent in the periodontal disease36 and a probe pair was designed; the 
Probe set
Taxonomic 
level Phylum Zip Code
Streptococcus oralis and rel. Cluster Firmicutes 3
Streptococcus mutans Species Firmicutes 1
Lactobacillus acidophilus Species Firmicutes 23
Gemella Genus Firmicutes 5
Staphylococcus Genus Firmicutes 29
Parvimonas micra Species Firmicutes 9
Selenomonas Genus Firmicutes 7
Veillonella Genus Firmicutes 15B
Leptotrichia Genus Fusobacteria 8
Fusobacterium Genus Fusobacteria 15
Propionibacterium Genus Actinobacteria 17
Actinomyces Genus Actinobacteria 12
Treponema denticola and rel. Cluster Spirochaetes 1B
Eikenella Genus Proteobacteria 21
Haemophilus parainfluenzae and rel. Cluster Proteobacteria 27
Aggregatibacter actinomycetemcomitans Species Proteobacteria 31
Campylobacter Genus Proteobacteria 6
Capnocytophaga Genus Bacteroidetes 41
Porphyromonas gingivalis Species Bacteroidetes 39
Prevotella denticola and rel. Cluster Bacteroidetes 33
Prevotella intermedia and rel. Cluster Bacteroidetes 35
Prevotella melaninogenica and rel. Cluster Bacteroidetes 37
Table 1. Bacterial targets of the OralArray, the taxonomic level, the phylogenetic classification and the Zip 
Code associated in the array.
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genera Selenomonas and Veillonella are the most representative of the Veillonellaceae family37 and were targeted 
by two genus-level probe sets. The phylum Fusobacteria includes the genera Fusobacterium and Leptotrichia, 
frequently detected in oral samples, as well as in other human ecosystem, and were recognized by two genus-level 
probe sets, both already validated in previous LDR-UA-based assays (HTF-MicroBi.Array25 and VaginArray26, 
respectively). Within the phylum Actinobacteria, Actinomyces and Propionibacterium genera have been associated 
to gingivitis and dental caries38 and have been addressed by two genus-level probe sets. All human oral taxa iden-
tified to date in the phylum Spirochaetes are members of the genus Treponema37, in particular the most recurrent 
species T. denticola and T. putidum, thus a group-specific probe pair was designed. For the phylum Proteobacteria, 
two genus-specific probe sets were included; one, specifically designed to detect the genus Eikenella, the other, 
targeting the genus Campylobacter, has been already reported in Candela et al.25. In addition, a probe set address-
ing the peri implantitis-related species Aggregatibacter actinomycetemcomitans and a probe set for the healthy 
Figure 1. Phylogenetic tree of the oral microrganisms targeted by the OralArray. The tree was obtained from 
the entire positive set used for the probe design. The neighbor-joining method was used to infer evolutionary 
history. The evolutionary distances were computed using the maximum composite likelihood method and 
units correspond to the number of base substitutions per site. The analysis involved 383 nucleotide sequences 
(Supplementary Table S2). All positions containing gaps and missing data were eliminated. Evolutionary 
analyses were conducted by using MEGA6 software.
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marker Haemophilus parainfluenzae and the related species H. ducreyi and H. pittmaniae were developed. Among 
Bacterioidetes phylum, Prevotella is the largest genus and was addressed by three group-specific probe sets: the 
first recognized P. denticola and the related species P. multiformis, the second recognized P. intermedia, P. falsenii, 
and P. nigrescens, the last detected P. melaninogenica and the related species P. veroralis and P. histicola. For the 
Bacterioidetes phylum, the genus Capnocytophaga and the periodontitis-associated species Porphyromonas gingi-
valis were selected and targeted in the array, too.
The newly designed probes had an average melting temperature (Tm) of 67.7 ± 0.3 °C (n = 34) and an average 
length of 36 ± 5.3 nucleotides (Supplementary Table S1). Seven probes out of thirty-four contained degenerated 
bases, in particular four probes contained only one ambiguous base, one probe contained 2 ambiguous bases and 
two probes contained 3 ambiguous bases.
Validation of the OralArray on DNA samples from pure bacterial cultures: specificity, repro-
ducibility and sensitivity. The specificity of the designed probe sets was tested by using 10 ng of 16 S rRNA 
PCR products from twenty-two microorganisms, members of the human oral microbiota (Table 2). Moreover, 
the probe sets designed for HTF-MicroBi.Array25 and the VaginArray26 (already validated towards gastrointesti-
nal and vaginal microorganisms, respectively) were subjected to specificity tests by using oral microbial species. 
Amplicons were prepared by PCR of genomic DNA provided by DSMZ or extracted from pure cultures. All 16 S 
rRNA amplicons were properly recognized in separate LDR hybridization reactions with the entire probe panel 
of the array: only probes associated with the expected species and control spots were significantly over the back-
ground, with P-values < 0.0005. Signal-to-noise ratios (SNR) calculated for the spots called as significant (sSNR) 
varied from 12.94 to 279.57, with an average of 64.96, whereas SNR of the remaining spots (not significant spots, 
nsSNR) varied from 0.89 to 1.71, with an average of 1.36 (Table 2).
With the purpose to evaluate the reliability of the OralArray, each 16 S rRNA amplicon was subjected to at 
least four independent LDR-UA experiments, and all replicates gave the correct detection (data not shown). 
Hence, the OralArray showed a complete reproducibility (100%) on 16 S amplicons prepared from oral target 
bacteria.
In order to define the detection limit of the OralArray, LDR-UA experiments were carried out with decreas-
ing amounts of 16 S rRNA amplicons, in the range from 8 to 1 ng (corresponding to 5.6–0.7 fmol, respectively). 
All amplicons were correctly detected showing P-values below 0.005, even at the lowest amount, thus defin-
ing the sensitivity limit of the tool to 1 ng, which corresponds to 0.7 fmol of PCR product. Notably, sSNR val-
ues decreased along with gradually reducing template concentration, showing an average Pearson correlation 
coefficient of 0.84 ± 0.20. In addition, sensitivity experiments were carried out on artificial mixes of 16 S rRNA 
amplicons, containing equal amounts of PCR amplicons obtained from six/four members of the human oral 
microbiota. All targets were specifically recognized even at the lowest amount, confirming the low sensitiv-
ity limit of the OralArray. Even in these DNA mixes, a linear correlation between sSNR values and 16 S rRNA 
amplicon amounts was observed (Fig. 2a–d). In order to evaluate the potential interference of human DNA with 
Probe set Species P-value sSNR nsSNR
S. oralis and rel. S. oralis 7.20 × 10–9 168.65 1.61
S. mutans S. mutans 2.49 × 10-6 60.06 1.61
L. acidophilus L. acidophilus 9.24 × 10−7 51.45 1.56
Gemella G. morbillorum 2.04 × 10−4 100.48 1.52
Staphylococcus S. aureus 1.81 × 10−4 55.16 1.23
P. micra P. micra 2.85 × 10−6 16.77 1.38
Selenomonas S. noxia 1.17 × 10−6 100.34 1.71
Veillonella V. parvula 4.27 × 10−6 127.11 1.45
Leptotrichia L. buccalis 1.76 × 10−8 12.94 0.89
Fusobacterium F. nucleatum subsp. polymorphum 5.56 × 10
−11 279.57 1.67
Propionibacterium P. acidifaciens 3.34 × 10−12 143.65 1.32
Actinomyces A. odontolyticus 5.14 × 10−5 42.00 1.23
T. denticola and rel. T. denticola 2.31 × 10−8 34.89 1.50
Eikenella E. corrodens 2.17 × 10−6 14.85 1.36
H. parainfluenzae and rel. H. parainfluenzae 2.87 × 10−4 44.89 1.17
A. actinomycetemcomitans A. actinomycetemcomitans 4.77 × 10−5 14.02 1.34
Campylobacter C. sputorum subsp. sputorum 3.43 × 10−5 40.55 1.32
Capnocytophaga C. sputigena 3.60 × 10−4 22.72 1.09
P. gingivalis P. gingivalis 1.36 × 10−6 30.22 1.15
P. denticola and rel. P. denticola 3.86 × 10−5 25.14 1.34
P. intermedia and rel. P. intermedia 2.37 × 10−7 26.10 1.33
P. melaninogenica and rel. P. melaninogenica 1.09 × 10−6 17.57 1.22
Table 2. Bacterial species used for specificity tests, P-values, probe specific (sSNR) and not specific (nsSNR) 
signal-to-noise ratios.
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the OralArray analysis, a set of LDR-UA experiments was performed in the presence of human genomic DNA. 
Also in these experimental conditions, the targets were correctly detected and sSNR values correlated with DNA 
amounts (average Pearson correlation coefficient 0.97 ± 0.02) (Fig. 2e).
Given the good linear correlation between sSNR values and 16 S rRNA amplicon amounts, the OralArray 
could be potentially employed for semi-quantitative analysis or relative quantification. The average ratio between 
sSNR and DNA amount was used to estimate probe efficiency. Efficiency coefficients were, then, employed to 
scale IF data.
Figure 2. Sensitivity of the OralArray on DNA mixes. Artificial mixes of 16 S rRNA amplicons were subjected 
to LDR-UA analysis, sSNR values were plotted vs ng of each DNA amplicon. sSNR values were obtained with 
decreasing amounts of DNA mixes containing: (a) S. oralis, S. aureus, P. micra, P. acidifaciens, A. odontolyticus, 
and E. corrodens 16 S rRNA amplicons (8–1 ng each); (b) G. morbillorum, L. buccalis, F. nucleatum, T. 
denticola, C. sputigena, and P. gingivalis 16 S rRNA amplicons (8–1 ng each); (c) H. parainfluenzae, A. 
actinomycetemcomitans, C. sputorum, P. denticola, P. intermedia, and P. melaninogenica 16 S rRNA amplicons 
(8–1 ng each); (d) S. mutans, L. acidophilus, S. noxia, and V. parvula 16 S rRNA amplicons (8–1 ng each); (e) S. 
oralis, G. morbillorum, A. odontolyticus, and P. melaninogenica 16 S rRNA amplicons (8–1 ng each) added with 
human genomic DNA up to 100 ng of total DNA (68–96 ng).
www.nature.com/scientificreports/
6SCIeNTIfIC REPORTS | 7: 6280 | DOI:10.1038/s41598-017-06743-6
Validation of the OralArray on clinical oral samples. The new tool OralArray was applied to investi-
gate the bacterial signature of thirty-six oral specimens collected from ten patients at four different oral sites, i. 
e. saliva, lingual plaque, supragingival plaque, and healing cap. For five patients (namely P1 to P5), samples of 
saliva, lingual plaque, supragingival plaque were collected; for the other five patients (P6 to P10), samples corre-
sponding to healing caps were also available. For all samples, total DNA was extracted, the bacterial 16 S rRNA 
gene was amplified and analysed by LDR-UA. Firstly, four samples, representative of the four different oral sites, 
were subjected to two separate LDR-UA experiments, in order to establish the reproducibility of the analysis on 
clinical samples. For each experiment, a profile of presence/absence of probe response was obtained, considering 
a threshold value P = 0.01 for significance. The OralArray has proved to be applicable to oral samples of differ-
ent origin, and showed a reproducibility of 97.7% (calculated as the percentage of the probes giving the same 
response in the technical replicates). Indeed, the cluster analysis of the microbial profile obtained with OralArray 
showed that replicates clustered together, showing very high cluster stability values ranging from 85 to 100 (Fig. 3, 
Supplementary Fig. S1).
Subsequently, the analysis was conducted on the entire set of samples and results are visualized in Fig. 4. 
Streptococcus oralis (or related species) was ubiquitously detected in all specimens, the genus Actinomyces 
was the second most common bacterial target, detected by the OralArray in 78% of the samples. The genera 
Fusobacterium and Veillonella were, also, very frequently identified (58% and 56% of the samples, respectively), as 
well as Prevotella melaninogenica (or related species), present in half of the samples. Gemella and Staphylococcus 
genera were, also, quite common in the oral samples, being positive in 42% and 39% of the specimens, respec-
tively; on the other hand, Leptotrichia and Capnocytophaga genera were found in 28% and 25% of the sam-
ples analysed. The bacterial targets S. mutans, Selenomonas, Propionibacterium, Eikenella, H. parainfluenzae (or 
related species), Campylobacter, P. gingivalis, and P. intermedia were only seldom detected (3–8%). Finally, L. 
acidophilus, P. micra, T. denticola (and related species), A. actinomycetemcomitans, and P. denticola were never 
found in the analysed samples.
In order to search for possible correlations between oral microbiota composition and individual or sample 
type (oral site of collection), the entire set of quantitative IF data collected from OralArray were subjected to anal-
ysis of variance (ANOVA). We, firstly, sorted samples on the basis of the subject, grouping together saliva, lingual 
plaque, supragingival plaque, and healing cap data of each patients, and we found that the microbial signature was 
significantly different in relation to the subject considered (P = 0.0273). When the statistic test was applied only 
to saliva, lingual plaque, and supragingival plaque data, the differences in the microbiota between individuals was 
highly significant (repeated measures ANOVA, P < 0.0001). On the contrary, the oral site of collection did not 
significantly affect the bacterial community composition. Indeed, when we grouped data on the basis of the sam-
ple type (saliva, lingual plaque, supragingival plaque, and healing cap) we found a high variability (P = 0.0582). 
Thus, samples collected from the same individual were sorted together and average relative abundance was cal-
culated (Fig. 5). As expected, all subjects were quantitatively dominated by Firmicutes, with an average relative 
abundance of 67.7% ± 17.5%. Notably, Firmicutes exceeded 80% of abundance in P2, P3, and P6 subjects. In 
particular, S. oralis (and related species) was the highest signal in eight out of ten individuals, whereas Veillonella 
was predominant in P6 and P7 samples. Bacterial targets belonging to the phylum Fusobacteria were detected in 
the oral microbiota of nine individuals, with variable relative abundance, ranging from 30% to 1.5%; Leptotrichia 
signal was predominant in six individuals, whereas, in the other three, only Fusobacterium was detected (P2, P3, 
Figure 3. Reproducibility of the OralArray analysis on oral samples. Four samples, representative of four 
different oral sites (S: saliva, L: lingual plaque, P: supragingival plaque, C: healing cap), were subjected to two 
separate LDR-UA experiments (a,b). Response of each probe set for the presence/absence of the bacterial target 
is displayed: black: positive response (P < 0.01); white: negative response (P > 0.01).
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and P8). Members of the genus Actinomyces (phyum Actinobacteria) were retrieved in eight individuals, three 
of whom were, also, characterised by the presence of Propionibacterium (P8, P9, and P10). Representatives of 
the phylum Bacterioidetes were found in the oral microbiota of nine subjects (all subjects except P3), all being 
positive for P. melaninogenica (or related species) and five to Capnocytophaga; the bacterial targets P. intermedia 
(or related species) and P. gingivalis, on the other hand, were detected only in one individual (P1 and P7, respec-
tively). Finally, evidence of a presence of microorganisms belonging to the Proteobacteria phylum was found only 
in the oral samples of two individuals (P1 and P3): P1 was colonised by Eikenella and Campylobacter genera, P3 
by H. parainfluenzae (or related species).
Concerning the oral site of sample collection, although it did not significantly affect the bacterial commu-
nity composition, it is worth to notice that some bacterial targets were preferentially or exclusively detected in 
a particular oral sample type. Gemella and P. melaninogenica (and related species) were prevalently found in 
saliva and lingual specimens rather than in plaque and healing caps. Indeed, Gemella was detected in eight saliva 
samples out of ten, and in half of lingual samples, but only in two plaque specimens and never in healing caps. 
Analogously, P. melaninogenica was found positive in seven saliva and eight lingual samples out of ten, while only 
in two plaques out of ten, and one healing cap out of six. Bacteria of the genus Capnocytophaga were detected 
only in samples collected from supragingival plaque (five out of ten) and healing caps (four out of six). In general, 
supragingival plaque was characterised by the largest variety of bacterial targets, indeed S. mutans, Selenomonas, 
Figure 4. Heatmap of the OralArray data. Samples were collected from ten subjects (P1-P10) at four oral sites 
(S: saliva, L: lingual plaque, P: supragingival plaque, C: healing cap) and analyzed by OralArray. Fluorescence 
intensities (IFs) were normalized over the IFs of the Zip Code 63, as described in the Methods section. The 
mean values of the logarithm of IFs (n = 4) for each bacterial target are plotted in a scale of grey, by using R 
“made4” package. Prevalence of bacterial targets in the oral samples are also reported, expressed in percentage 
(%).
Figure 5. Relative abundance of bacterial targets detected by the OralArray, grouped for individual. For each 
individual (P1-P10), fluorescence intensities of saliva, lingual plaque, supragingival plaque, and healing cap 
were grouped and average relative contributions were calculated as percentage of the total fluorescence intensity.
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Propionibacterium, Eikenella, H. parainfluenzae (or related species), and P. gingivalis were detected only in plaque 
samples.
Application of the OralArray to evaluate the effects of chlorhexidine treatment to healing caps 
before the usage. Given the good performance of the OralArray on oral clinical samples, the tool was 
employed to evaluate the effects of a disinfectant treatment on healing caps before their usage. For this purpose, 
patients under treatment for a prosthetic rehabilitation on at least two implants were enrolled. One implant was 
sealed with a sterile healing cap, the other one with a sterile healing cap previously immersed in chlorhexidine 
0.2% solution. Healing caps were collected after two weeks, total bacterial DNA was isolated and amplified, and 
successively analysed by OralArray. Six pairs of healing caps were considered (C1-C6), and the bacterial com-
munity composition of paired control and chlorhexidine-treated healing caps was compared (Fig. 6). For C1, C4, 
C5, C6, the treatment with the disinfectant resulted in a reduced microbial complexity, in terms of number of 
bacterial targets detected. Indeed, in C1 chlorhexidine treatment caused a reduction of complexity from five to 
three bacterial targets, in C4 from five to two, in C5 from six to four, and in C6 from seven to three. On the other 
hand, chlorhexidine treatment had opposite effect on the microbial complexity of C2 and C3 healing caps pairs, 
which shifted from three to nine, and four to five, respectively. In addition, no correlation was found between the 
IF intensity registered by the OralArray and the chlorhexidine treatment, indicating no quantitative changes in 
bacterial populations induced by chlorhexidine.
Discussion
The quali-quantitative characterization of the oral microbiota is crucial for an exhaustive knowledge of the oral 
ecology and the modifications of the microbial composition that occur during the most common periodontal 
pathologies. Among these, perimplant mucositis and perimplantitis are emerging problems related to the increas-
ing use of dental implants, negatively affecting the success rate of the prosthetic rehabilitation39.
In the present study, we described the development and validation of a phylogenetic DNA-microarray spe-
cifically designed for the oral microbiota (OralArray), capable to detect the most representative bacterial groups 
that colonize the oral cavity in healthy and pathological conditions. Our array is based on the ligation detection 
reaction (LDR), a molecular assay which possesses inherent advantages over microarrays whose discriminative 
power is based on hybridization. Ligation-based assays are based on a Pfu thermostable DNA ligase that seals 
Figure 6. Heatmap of the OralArray data of control and chlorhexidine treated healing caps. Control and 
chlorhexidine-treated healing caps were put on the implants for two weeks, then collected, and bacterial 
signature depicted by OralArray. Fluorescence intensities (IFs) were normalized over the IFs of the Zip Code 63, 
as described in the Methods section. The mean values of the logarithm of IFs (n = 4) for each bacterial target are 
plotted in a scale of grey, by using R “made4” package. C1-C6 referred to healing cap pairs. CHX: chlorhexidine.
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the nick between the “discriminating” and the “common” probes only when there is a perfect match between the 
two and the template. Therefore a single mismatch in 3′ terminal position of the discriminating probe is enough 
to prevent ligation40. Other advantages of the LDR-UA format are less problems during hybridization due to the 
secondary structures of the target DNA and steric hindrances and the fact that all Zip Codes have been designed 
in order to have the same melting temperature and do not need further optimization in the hybridization step25. 
LDR-UA, thus, allows high performance in terms of sensitivity and discriminatory power and combines the high 
throughput of microarrays with the versatility of the PCR.
Indeed, the OralArray includes probe pairs targeted to microbial species or genera that characterize the 
healthy mouth, as well as bacteria involved in dental caries, periodontal disease, and perimplantitis3, 5, 32, 33.
However, emerging data sustain the “ecological plaque hypothesis” to explain the etiology of the most prev-
alent oral diseases: such hypothesis ascribes the onset of an oral disease to a dysbiosis of the resident oral micro-
flora, driven by an ecological perturbation, rather than the colonization of specific pathogen microbes responsible 
for particular infections6, 11, 12, 41. In this perspective, the detection/quantitation of a pool of putative ‘pathogenic’ 
microbial species should be addressed by molecular tools, in order to monitor microbiota compositional fluctua-
tions for the correct diagnosis or susceptibility assessment of oral polymicrobial diseases.
The OralArray analysis has been proved highly specific, reproducible and sensitive. The tool was able to detect 
all tested oral-related 16 S rRNA amplicons without ambiguity, with a reproducibility of 100%. The detection 
limit, corresponding to 1 ng (0.7 fmol) of PCR product for all probe sets, was equal or lower than that calcu-
lated for other LDR-UA based DNA microarrays (HTF-MicroBi.Array: 0.7–75 fmol25; VaginArray: 6–12 ng26). 
Moreover, a major feature of the OralArray is the good linear correlation between IF signals (expressed as sSNR) 
and DNA template concentration, which enables the potential employment of the tool for semi-quantitative anal-
ysis and relative quantification. However, it must be stressed that the main goal of our phylogenetic array is the 
representation of the relative abundance of selected dominant bacteria within a complex ecosystem, such as the 
oral cavity.
Although the advent of next-generation sequencing techniques in microbial ecology is allowing the detection 
of the full bacterial community of human microflora (including oral) at reasonable costs, the OralAray permits 
a faster and cheaper detection of the most important bacterial groups in samples from oral sites. Each LDR-UA 
experiment costs down to about 6 euros per sample, including array production, probe synthesis and ligation, and 
takes about 7 hours to be performed, including ligation, hybridization on UA and scanner detection. NGS tech-
niques, on the other hand, can be useful to discover new potentially interesting targets to be addressed; thanks to 
the flexibility of the LDR-UA, the platform can be easily implemented with up to a total of forty-seven probeset 
per array in the current configuration.
The OralArray has been applied to oral samples collected from different oral sites, as well as healing caps, and 
microbial signatures were successfully obtained from all different oral samples.
It has been reported that healthy oral microbiota is characterized by a conserved microbial fingerprint at the 
genus level, but large inter-individual differences were also evidenced, especially at species and strain level9, 42. In 
addition, similarities between microbial communities detected on teeth, tongue samples, and implants collected 
from the same individual were found43, 44. Our data strengthened the presence of an individual oral microbial 
profile, given that the detected microbial panel is significantly different in relation to the subject analysed.
We failed to demonstrate a statistic correlation between the bacterial communities composition and the oral 
site of sample collection. Nevertheless, some bacterial targets were prevalent in particular oral sample types, and 
our findings are in agreement with data previously reported in literature obtained by NGS45. These authors delin-
eated the core bacterial taxa in the oral cavity from over two-hundred individuals participating in the Human 
Microbiome Project, reporting that saliva and lingual plaque core microbiomes include Prevotella species, and 
supragingival plaques are highly colonised by Capnocytophaga. The concordance of our findings with the NGS 
data already published represents a further element that supports the validity of our array as a phylogenetic tool.
The OralArray was, also, applied to evaluate the efficacy of a disinfectant treatment on the healing caps before 
their usage: no significant differences in the microbial community composition were noticed between control and 
disinfectant-treated healing caps.
In conclusion, in the present paper, we reported the development and validation of a new phylogenetic tool 
specifically designed for the oral microbiota. We demonstrated that the OralArray is able to efficiently and quickly 
delineate the core bacterial signature of various oral sample types, including healing caps, and can be easily 
applied in clinical trials.
Methods
Selection of bacterial targets and consensus extraction. Bacterial genera, cluster of phylogenetically 
related species or single species representative of the human oral ecosystem were rationally selected on the basis 
of the available literature3, 5, 30–34. For such bacteria, 16 S rRNA gene sequences were retrieved from Ribosomal 
Database Project46 (RDP, http://rdp.cme.msu.edu/) (named ‘positive set’) and group-specific consensus sequences 
were extracted with a cut-off of 75% for base calling (i.e.: for each position, the consensus reports the nucleotide 
present in at least ¾ of the positive set sequences). Nucleotides which occurred at lower frequencies were replaced 
by the appropriate IUPAC ambiguity code. Analogously, for each target of the array, a “negative set” of 16 S rRNA 
sequences was built, which includes sequences each probe set should not target.
Design of common and discriminant probes. Selected sequences were subjected to multiple align-
ments by ClustalW47. All the LDR probe pairs were designed by using ORMA35 following the procedure used 
for the HTF-MicroBi.Array25. Briefly, for each target, a DP and a CP were designed on the appropriate consensus 
sequence, identifying a region capable to discriminate sequences belonging to positive and negative sets. Both 
DP and CP were required to be between 25 and 60 bases pair, with a melting temperature (Tm) of 68 ± 1 °C, and 
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with maximum 4 degenerated bases. A cZip Code was added at the 3′ end of each CP, a Cy3 label was attached to 
the 5′ end of each DP. Specificity and coverage of each candidate probe was assessed in silico using the tool Probe 
Match of the RDP database. The probe pairs were required to perfectly match the sequences of the positive set 
and to possess at least one mismatch at the 3′ end of the discriminating probe respect to the entire negative set.
Bacterial genomic DNA. Genomic DNA from Streptococcus agalactiae DSM2134, Streptococcus mutans 
DSM20523, Streptococcus oralis DSM20627, Gemella morbillorum DSM20572, Selenomonas noxia DSM19578, 
Veillonella parvula DSM2008, Parvimonas micra DSM20468, Actinomyces odontolyticus DSM19120, 
Propionibacterium acidifaciens DSM21887, Eikenella corrodens DSM8340, Campylobacter sputorum subsp. sputo-
rum DSM10535, Haemophilus parainfluenzae DSM8978, Aggregatibacter actinomycetemcomitans DSM8324, 
Prevotella denticola DSM20614, Prevotella intermedia DSM20706, Prevotella melaninogenica DSM7089, 
Porphyromonas gingivalis DSM20709, Capnocytophaga sputigena DSM7273, Fusobacterium nucleatum subsp. 
polymorphum DSM20482, Leptotrichia buccalis DSM1135, and Treponema denticola DSM14222 was directly 
obtained from the DSMZ (Braunschweig, Germany).
Bacterial DNA from Lactobacillus acidophilus DSM20079 and Staphylococcus aureus ATCC12600 was 
extracted from 109 bacterial cells by using the DNeasy Blood and Tissue Kit (Qiagen, Düsseldorf, Germany) 
following the manufacturer instructions. L. acidophilus was grown on De Man-Rogosa-Sharpe (MRS) broth with 
cysteine (0.5 g/L) at 37 °C, under an anaerobic atmosphere (Anaerocult, Merck, Darmstadt, Germany). S. aureus 
ATCC12600 was grown at 37 °C aerobically on Luria-Bertani (LB) broth.
Collection of oral samples. Oral samples were collected in the field of routine clinical practice in the 
Dental Clinic ASST Santi Paolo e Carlo, University of Milan (Milan, Italy). The ethical board of the ASST Santi 
Paolo e Carlo gave the approval for this study (2016/ST/085). The patients enrolled had to understand and sign a 
voluntary informed consent. The methods were performed in accordance with the approved guidelines. Systemic 
exclusion criteria were: medical conditions requiring prolonged use of steroids, severe hemophilia, bisphospho-
nate medication, history of leukocyte dysfunction and deficiencies, history of head and neck radiation or chemo-
therapy, history of renal failure, history of uncontrolled endocrine disorders, physical handicaps interfering with 
ability to perform adequate oral hygiene, alcoholism or drug abuse, HIV infection, smoking >10 cigarettes or 
cigar equivalents per day. Local exclusion criteria were: local inflammation, including untreated periodontitis, 
mucosal diseases such as erosive lichen planus, history of local irradiation therapy, persistent intraoral infection, 
patients with inadequate oral hygiene or unmotivated for adequate home care. Patients had not received any anti-
microbial treatment in the three months before the enrollment. A total of ten patients were included (six females, 
four males, mean age 46.7 years). Among these, five patients were under treatment for a prosthetic rehabilitation 
on at least 2 Straumann RN implants (Insitute Straumann AG, Basel, Switzerland). The oral samples were col-
lected as follows: 1) non-stimulated saliva: the patient was asked to collect his non-stimulated saliva over a period 
of 5 min in a sterile tube; 2) lingual plaque: a gentle air flow was used to remove superficial saliva from the tongue, 
then a sterile cotton pellet was brushed on the tongue for 30 s and, then, released in a sterile tube filled with 
1 mL of saline solution; 3) supragingival plaque: a gentle air flow was used to remove superficial saliva from the 
teeth, then, a sterile cotton pellet was brushed on dental surfaces of posterior elements for 30 s and, subsequently, 
released in a sterile tube filled with 1 mL of saline solution; 4) implant healing caps: one implant was washed with 
saline solution internal irrigation for 30 s and, then, dried off with a gentle blow of air; the corresponding healing 
cap was immersed in saline solution for one minute just before tightening on the implant. The other implant was 
washed with 0.2% chlorhexidine solution internal irrigation, then dried off, and the healing cap was immersed 
in 0.2% chlorhexidine solution before tightening on the implant. After two weeks, healing caps were collected in 
sterile tubes filled with 1 mL of saline solution. All tubes were sealed, and stored at −80 °C immediately after the 
sample collection.
Extraction of genomic DNA from oral samples. Total bacterial DNA was extracted from oral samples 
as described by Cruciani et al.48 with slight modifications: 0.5–1 mL of each specimen was centrifuged at 10,000 g 
for 15 min and the pellet was directly resuspended in 180 μL of enzymatic lysis buffer (20 mM Tris-HCl pH 8, 
2 mM EDTA, 1.2% Triton X-100, 20 mg/mL lysozyme) and incubated at 37 °C for 30 min. 200 mg of glass beads 
were added and the sample was mixed by vortexing for 1 min. Total DNA was extracted by using the DNeasy 
Blood and Tissue kit following the protocol “Pretreatment for Gram-positive bacteria”. DNA was quantified by 
using NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE).
PCR conditions. All the oligonucleotide probes were synthesized by Thermo Fisher Scientific (Ulm, 
Germany). 16 S rRNA gene was amplified by using a Biometra Thermal Cycler II (Biometra, Gottingen, Germany) 
and 2.5 U of GoTaq Flexi polymerase (Promega, Madison, WI) in a final volume of 50 μL following the protocol 
described in Cruciani et al.26. PCR products were purified by using a High Pure PCR Clean up Micro kit (Roche, 
Mannheim, Germany), following the manufacturer instructions, and quantified by NanoDrop ND-1000.
LDR-UA conditions. The experimental procedure for both the chemical treatment and the spotting of 
UA is described in detail in Consolandi et al.49. Briefly, each UA consists of synthetic oligonucleotides, called 
Zip Codes, each printed in quadruplicate within the printing area; two Zip Codes, namely 63 and 66, act as 
ligation and hybridization controls, respectively; pure printing buffer was used as a negative control (blank). 
Each printed slide contains 8 UAs, each being a 13 × 16 matrix of a total of 208 spots of nominal diameter 
size of about 120–150 μm (Supplementary Fig. S2). Ligase Detection Reactions (LDRs) were carried out in a 
final volume of 20 μL containing 250 fmol of each specific probe (CP and DP), 25 fmol of a synthetic template 
(5′-AGCCGCGAACACCACGATCGACCGGCGCGCGCAGCTGCAGCTTGCTCATG-3′, recognized by a 
specific set of probes bearing cZip Code 63), 4 U of Pfu DNA ligase (Agilent Technologies, Palo Alto, CA) and 
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appropriate amount of PCR product. In specificity tests 10 ng of PCR product were used. Three different sensitiv-
ity tests were performed as follows: a) decreasing amounts from 8 ng to 1 ng of single PCR product, b) decreasing 
amounts from 48 ng to 6 ng of PCR product mixes composed by six different 16 S RNA amplicons or decreasing 
amounts from 24 ng to 4 ng of PCR product mixes composed by four different 16 S RNA amplicons, c) decreasing 
amounts from 24 ng to 4 ng of PCR product mixes composed by four different 16 S RNA amplicons added with 
increasing amounts of human genomic DNA up to 100 ng of total DNA content. In human oral samples analyses, 
48 ng of PCR product were used. Prior to LDR, the DNA was denatured at 95 °C for 5 min; then, the reaction was 
cycled for 30 rounds at 94 °C for 30 s and at 60 °C for 4 min, in a Biometra Thermal Cycler II (Biometra). Before 
hybridization, LDR mixtures were diluted as described in Castiglioni et al.28 and 100 fmol of cZip 66 oligonucle-
otide (complementary to Zip Code 66, 5′-Cy3-GTTACCGCTGGTGCTGCCGCCGGTA-3′) plus 6 ng of salmon 
testes DNA were added. Zip Code 66 (hybridization control) and Zip Code 63 (ligation control) were used for 
locating the sub-matrixes during the scanning and for normalization purposes, respectively.
UA scanning and data analysis. Arrays were scanned by using a ScanArray 5000 scanner (Perkin Elmer 
Life Sciences, Boston, MA) at 10 µm resolution and the fluorescence intensity (IF) was quantitated by ScanArray 
Express 3.0 software, as previously described26. IFs were subjected to a normalization procedure based on the IFs 
of the Zip Code 63, which is added to LDR mixes in fixed amounts, applied as follows: (a) outlier values (2.5-fold 
above or below the average) were discarded; (b) a correction factor was calculated in order to set the average IF 
of Zip Code 63 to 50000 (n = 6); (c) the correction factor was applied to both the probe spots and background 
IF values. Significantly present spots were determined using a one-tailed t-test comparing, for each Zip Code, 
the distribution of IFs along all replicates (n = 4) with the distribution of IFs of negative controls (i.e.: “Blanks”, 
where only printing buffer has been spotted) (n = 6). Eventual outliers (those spots showing an IF 2.5-fold above 
or below the average) were discarded before performing the test. A P value = 0.01 was considered as a threshold 
for significance. The signal-to-noise ratio (SNR) was calculated as the ratio between the average IF of each probe 
and the average IF of Blank spots.
Statistical analysis. Statistical analysis was performed by using GraphPad software (GraphPad software 
Inc., San Diego, CA). Hierarchical clustering of LDR-UA detection signals (a 0/1 matrix where “1” means a posi-
tive signal for the corresponding probe, a “0” otherwise) was performed using Pearson correlation as metric and 
average linkage. Cluster stability was determined in R (v 2.13.2) by pvclust package (v 2.0.0)50.
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